COMMUNIQUÉS West-GlobeNewswire

Eyenovia to Participate in Panel Presentation at OSN New York 2018
19/09/2018
CEO Sean Ianchulev to join industry panel discussion on “Medical and Surgical Management of Corneal Conditions and Complications” NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a [...]
Zosano Pharma Completes Manufacture of M207 Registration Batches
19/09/2018
FREMONT, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018
19/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterials addressing multi-drug [...]
Spero Therapeutics to Present at the Cantor Global Healthcare Conference in October
19/09/2018
CAMBRIDGE, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
BioSig Technologies to Commence Trading on the Nasdaq
19/09/2018
Trading to Begin on the Nasdaq Capital Market on September 21, 2018 Santa Monica, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( OTCQB:BSGM, OTCQB:BSGMD ), a medical device company developing a [...]
Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
19/09/2018
REDWOOD CITY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]
Cynata’s Cymerus™ MSCs Ameliorate Cytokine Release Syndrome in Preclinical Study
19/09/2018
• Cymerus MSCs demonstrate substantial protection against CRS symptoms, a serious adverse reaction caused by cancer immunotherapies such as CAR-T MELBOURNE, Australia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Australian stem [...]
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
19/09/2018
The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement [...]
Scilex Announces Pricing and Availability of ZTlido™ for the Commercial Launch of its First Product in October of 2018
19/09/2018
SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), today announced that the Wholesale Acquisition Cost (WAC) for [...]
AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018
19/09/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 19, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
The American Health Council Welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians
19/09/2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians for his outstanding contributions to the medical field. Dr. Bittner [...]
North Bud Farms to Begin Trading on the Canadian Securities Exchange
19/09/2018
TORONTO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc . (" NORTHBUD " or the " Company ") is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (“ CSE ”) at [...]
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences
19/09/2018
SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer Fall Summit Focused on Specialty [...]
Sonoma Pharmaceuticals Appoints Phillipe Weigerstorfer to Board of Directors
19/09/2018
PETALUMA, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the appointment of Philippe Weigerstorfer to the company’s board of directors. Weigerstorfer brings [...]
BeyondSpring Strengthens Intellectual Property Portfolio with Newly Granted U.S. Patent for Plinabulin
19/09/2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced today that the U.S. [...]
Ortho Regenerative Technologies Inc. Appoints Accomplished Life Science Executive, Luc Mainville, as CFO
19/09/2018
KIRKLAND, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Corporation”) (CSE: ORTH) today announced the appointment of Luc Mainville as Senior Vice President and [...]
Four Ogilvy CommonHealth Worldwide executives tapped to serve as jurors for three premier industry award shows
19/09/2018
PARSIPPANY, N.J., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP, www.wpp.com ), announced four top executives from the [...]
Helius Announces First Partnership to Implement Clinical Experience Programs With the Investigational PoNS™ Therapy in the United States
19/09/2018
NEWTOWN, Pa., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it has [...]
Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Alzheimer’s Disease Agitation
19/09/2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Pages